Open tender · Moldova · Pharmaceutical products
“Achiziționarea medicamentelor Dornase alfa 2500 U/2,5 ml și Tobramycinum 300 mg/4 ml, necesare IMSP Institutul Mamei și Copilului, pentru anul 2027”
In EnglishAcquisition of Dornase alpha 2500 U/2.5 ml and Tobramycinum 300 mg/4 ml medicines required by IMSP Mother and Child Institute for the year 2027
Centrul Pentru Achizitii Publice Centralizate in Sanatate
Centrul Pentru Achizitii Publice Centralizate in Sanatate in Moldova is inviting bids for “Acquisition of Dornase alpha 2500 U/2.5 ml and Tobramycinum 300 mg/4 ml medicines required by IMSP Mother and Child Institute for the year 2027”. Bids close on 16 October 2026, 17:15 EEST; the estimated value is MDL 2.23 million. askTender lists every requirement to qualify and checks whether your company meets them.
Key facts
- Estimated value
- MDL 2.23 million
- Published
- 15 Sep 2026
Before you bid, askTender
Everything else is in your askTender account
The requirements to qualify, the eligibility check and the bid documents for this tender are in your askTender account.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: MTender, Ministry of Finance of Moldova. · Sources & licences